Stock Comparison

ASND vs REGN

Ascendis Pharma AS and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ASND

Ascendis Pharma AS

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$16.14B

$80.55B

P/E (TTM)

28.1

19.4

Forward P/E

15.4

17.1

Price/Sales

18.6

5.2

Price/Book

28.7

2.5

EV/EBITDA

-20.0

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

58.40%

29.65%

Operating Margin

-0.80%

24.32%

Return on Equity

33.30%

14.00%

Return on Assets

-0.60%

6.53%

Growth (YoY)

Revenue Growth

144.30%

16.70%

Earnings Growth

0.00%

-4.50%

Price & Risk

Beta

0.5

0.2

52-Week High

$277.18

$810.12

52-Week Low

$189.74

$553.38

Analyst Target

$309.46

$833.54

Compare ASND and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.